Screening for hepatocellular carcinoma - IAGH

More documents

Recommendations

Info

ScreeningUS Sensitivity and SpecificityStudy Sensitivity SpecificityOkazaki, 1984 86% 99%Maringhini, 1988 90% 93%Tremolda, 1989 85% 50%Dodd, 1992 50% 98%Pateron, 1994 78% 93%Zhang, 1999 84% 97%
HCC: Screening Strategies and Frequency• US q 6-12 months and AFP q 6 months is the mostcommonly used strategy in Asia and U.S.• Rationale for 6-month screening interval• Doubling time: median = 6 mo
Page 5 and 6: Population-based Cancer Registry Da
Page 7: Rising Incidence of HCC(Last 2 deca
Page 10 and 11: Number of casesOverall trend in the
Page 12 and 13: Why is HCC Incidence Rising?Increas
Page 14 and 15: 1. HBVRisk factor of HCC in Iran•
Page 16 and 17: Low incidence of HCC In Iran??• M
Page 18 and 19: Multiple logistic regression analys
Page 20 and 21: HBV In PregnancyContinue the case:
Page 22 and 23: Perinatal Transmission riskMother:
Page 24 and 25: Risk with High Maternal HBV DNA- 31
Page 26 and 27: Teatment During PregnancyOutcomes:-
Page 28 and 29: Treatment Option for Chronic HBVInt
Page 30 and 31: AFP In PregnancyAFP produced byYolk
Page 32 and 33: Screening for chronic diseaseMust b
Page 34 and 35: • Imaging studies• Ultrasound*H
Page 38 and 39: HCC Screening: clinical studiesStud
Page 40 and 41: Zhang BH et al, J Cancer Res Clin O
Page 42 and 43: Zhang BH et al, J Cancer Res Clin O
Page 44 and 45: AASLD Recommendation for HCC survei

Screening for hepatocellular carcinoma - IAGH

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?